Atrial Fibrillation in Eight New World Camelids

• Published in: Journal of veterinary internal medicine 2016-01, Vol.30 (1), p.335-338
• Main Authors: Bozorgmanesh, R., Magdesian, K.G., Estell, K.E., Stern, J.A., Swain, E.A., Griffiths, L.G.
• Format: Article
• Language: English
• Subjects: Alpaca; Animals; Anti-Arrhythmia Agents - therapeutic use; Arrhythmia; Atrial Fibrillation - diagnosis; Atrial Fibrillation - therapy; Atrial Fibrillation - veterinary; Camelids, New World; Cardiac; Electric Countershock - veterinary; Female; FOOD AND FIBER ANIMAL; Llama; Male; Nerium - toxicity; Quinidine - therapeutic use
• ISSN: 0891-6640; 1939-1676
• DOI: 10.1111/jvim.13798

BACKGROUND: There is limited information on the incidence of clinical signs, concurrent illness and treatment options for atrial fibrillation (AF) in New World Camelids (NWC). OBJECTIVE: Describe clinical signs and outcome of AF in NWC. ANIMALS: Eight New World Camelids admitted with AF. METHODS: A retrospective observational study of camelids diagnosed with AF based on characteristic findings on electrocardiogram (ECG). RESULTS: All animals had an irregularly irregular heart rhythm detected on physical examination and 4 cases had obtunded mentation on admission. Three camelids were diagnosed with AF secondary to oleander intoxication, 3 animals had underlying cardiovascular disease, 1 was diagnosed with lone AF and 1 had AF diagnosed on examination for a urethral obstruction. Five of eight animals survived to discharge and nonsurvivors consisted of animals which died or were euthanized as a result of cardiovascular disease (2/8) or extra‐cardiac disease unrelated to the AF (1/8). CONCLUSIONS AND CLINICAL IMPORTANCE: Atrial fibrillation occurs in NWC in association with cardiovascular disease, extra‐cardiac disease or as lone AF. Amiodarone and transthoracic cardioversion were attempted in one llama with lone AF, but were unsuccessful. Atrial fibrillation was recorded in 0.1% of admissions.